First Patient Dosed in Jaguar Health’s Trial for Short Bowel Syndrome
Key TakeawaysJaguar Health announces the first patient dosed in a trial for short bowel syndrome with intestinal failure (SBS-IF).
The investigator-initiated study is...
Cosmos Health Develops AI-Powered Treatment for Multiple Sclerosis
Key TakeawaysCosmos Health has filed a new AI-driven patent for a multiple sclerosis (MS) treatment.
The patent is based on AI-powered drug repurposing...
Magdalena Biosciences to Present at BIO CEO & Investor Conference
Key TakeawaysMagdalena Biosciences, a Jaguar Health and Filament Health joint venture, will present at the BIO CEO & Investor Conference on February 10,...
Cosmos Health Expands GCC Distribution for Avian Flu PCR Kits
Key TakeawaysCosmos Health expands its exclusive agreement with Virax Biolabs to distribute avian influenza PCR kits across all GCC countries.
The new deal...
ICER Assesses Suzetrigine’s Value for Acute Pain Treatment
Key TakeawaysICER has published its final evidence report on suzetrigine for acute pain.
The treatment may be cost-effective, especially in reducing opioid use...
ICER Evaluates Gene Therapy for Retinitis Pigmentosa
Key TakeawaysICER has released a draft report on sonpiretigene isteparvovec for advanced retinitis pigmentosa.
Public comments are open until March 6, 2025, with...
Game-Changer: New Zealand to Fund Desogestrel Contraceptive for Wider Access
Key Takeaways
• Desogestrel accommodates those who cannot use estrogen-based pills.
• The extended dosing window enhances user convenience and adherence.
• Open to all eligible individuals...
BioAro Revolutionizes Genomic Medicine with PanOmiQ Launch
Key TakeawaysBioAro unveils the AI-driven PanOmiQ platform at PMWC 2025.
The technology delivers ultrafast genomic analysis, transforming precision medicine.
PanOmiQ democratizes access to...
Transgene and ProBioGen Collaborate on Personalized Cancer Vaccine Development
Key TakeawaysTransgene and ProBioGen partner to advance individualized cancer vaccine manufacturing.
Collaboration integrates ProBioGen’s AGE1.CR.pIX® cell line with Transgene’s myvac® platform.
The partnership...
Axsome Therapeutics Hosts Virtual Event on SYMBRAVO FDA Approval
Key TakeawaysAxsome Therapeutics hosted a virtual investor event to discuss SYMBRAVO’s FDA approval.
SYMBRAVO represents a novel treatment for migraines, targeting multiple pathways.
...
ProBioGen Expands Protein and Viral Manufacturing Capacity
Key TakeawaysProBioGen expands protein and viral manufacturing capabilities at its Berlin headquarters.
New 1000L-scale GMP production line and advanced viral platforms enhance global...
Brainomix 360 AI Validates Improved Stroke Treatment at ISC
Key TakeawaysBrainomix’s AI-powered Brainomix 360 platform shows transformative impact on stroke treatment rates.
New data presented at ISC demonstrates increased thrombolysis and thrombectomy...
FDA Approves SYMBRAVO for Rapid Migraine Relief
Key TakeawaysThe FDA has approved Axsome Therapeutics' SYMBRAVO for acute migraine treatment.
SYMBRAVO provides rapid and sustained relief, reducing the need for rescue...
Glucagon Awareness Campaign Tackles Low Prescription Rates
Key TakeawaysXeris Pharmaceuticals partners with the American Diabetes Association (ADA) to boost awareness of glucagon use for severe hypoglycemia.
Despite FDA approval, glucagon...
BioAge Advances Metabolic Disease Therapies
Key TakeawaysBioAge Labs is advancing its pipeline by discontinuing azelaprag development due to observed liver enzyme elevations and focusing on next-generation APJ agonists.
...
